PCRX Pacira BioSciences Inc
1,433
$31.01
$0.63
(2.07%)
| Watchers | 1,433 |
| 52-Wk Low | $25.33 |
| 52-Wk High | $42.63 |
| Market Cap | $1.41B |
| Volume | 970,747.00 |
| 52-Wk High | $42.63 |
| 52-Wk Low | $25.33 |
A Glimpse Into The Expert Outlook On Pacira BioSciences Through 6 AnalystsBenzinga • about 1 month ago
Latest Ratings for PCRX
DateFirmActionFromTo Feb 2022WedbushMaintainsOutperform Feb 2022HC Wainwright & Co.MaintainsBuy Jan 2022BarclaysMaintainsOverweight
View More Analyst Ratings for PCRX...
Share to Feed
Investors considering a purchase of Pacira BioSciences Inc (PCRX) shares, but cautious about paying the going market price of 29.22/share, might benefit from considering selling puts among the...
TAMPA, Fla., April 02, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 23rd Annual Needham Virtual...
This is a Bearish indicator signaling PCRX's price could decline from here. Traders may explore shorting the stock or put options...
This indicator may be signaling that PCRX's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
This is a Bullish indicator signaling PCRX's price could rise from here. Traders may explore going long the stock or buying call options...
This is a Bearish indicator signaling PCRX's price could decline from here. Traders may explore shorting the stock or put options...
-- PCRX-201 is the first gene therapy product candidate to receive RMAT designation for osteoarthritis -- -- Designation supported by encouraging preliminary data from 72-patient Phase 1 study...
This price move could indicate a change in the trend, and may be a sell signal for investors...
This indicator may be signaling that PCRX's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...